Skip to content

Evaluate the Predictive Impact of the EHMRG

Evaluate the Predictive Impact of the EHMRG Score for Patients Admitted to the Emergency Department With Final Diagnosis of Acute Heart Failure

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05632263
Acronym
EHMRGscore
Enrollment
1500
Registered
2022-11-30
Start date
2023-04-30
Completion date
2023-12-15
Last updated
2023-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergencies, Heart Diseases

Keywords

EHMRGscore, ACUTE HEART FAILURE

Brief summary

External validation of the EHMRG score for hospitalized patients with acute heart failure in the emergency department

Detailed description

It is a prospective cohort study carried out in the ED of Monastir which included patients admitted to the ED with a discharge diagnosis of AHF.

Interventions

DIAGNOSTIC_TESTEHMRGscore

validation of the EHMRG score for hospitalized patients with acute heart failure in the emergency department

Sponsors

University of Monastir
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* Patients consulted for acute dyspnea and were diagnosed with acute heart failure. * Major patient. * Subject who accept to participate in the research.

Exclusion criteria

* Patient who refuse to participate in the study. * Impossibility of giving the patient informed information

Design outcomes

Primary

MeasureTime frameDescription
EHMRGscore7daysThe primary outcome of interest is the EHMRG predictive accuracy to prognosticate 7-day mortality was measured by the athe area under the receiver operating characteristic curver (AUROC) with 95% confidence intervals.

Secondary

MeasureTime frameDescription
Re-admission rate 30-day re-admission rate30days30day ré-admission rate
Mortality rate Mortality rate at 30 days30dayMortality rate at 30 days

Contacts

Primary ContactNouira semir, Pr
semir.nouira@rns.tn73106046
Backup ContactBel Hadj Ali khaoula, MD
belhadjalikhaoula@yahoo.fr73106046

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026